Curr Drug Targets

• 

  Publication Venue For

  • Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers..  18:281-295. 2017
  • Recent Insights into Notch Signaling in Embryonal Rhabdomyosarcoma..  17:1235-1244. 2016
  • α7-Nicotinic receptors and cognition..  13:602-606. 2012
  • A pathway and approach to biomarker validation and qualification for osteoarthritis clinical trials..  11:536-545. 2010
  • Targets to tackle--the pathophysiology of the disease..  11:521-527. 2010
  • Waiting for action on the osteoarthritis front..  11:518-520. 2010
  • Group VI phospholipases A2: homeostatic phospholipases with significant potential as targets for novel therapeutics..  9:683-697. 2008
  • Wnt signaling in development, disease and translational medicine..  9:513-531. 2008